Open trial of methotrexate as treatment for autoimmune hearing loss
Eric L. Matteson(Mayo Clinic), Thomas J. McDonald(Texas A&M Health Science Center), George W. Facer(Mayo Clinic), Colin L. W. Driscoll(Mayo Clinic), David A. Fabry(Mayo Clinic), Charles W. Beatty(Mayo Clinic), Scott E. Strome(Northwestern Medicine Lake Forest Hospital)
Cited by 58
Related Papers
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
|Arthritis & Rheumatism|2012|6.6k
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5.1k
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
|Arthritis & Rheumatology|2015|2.8k
2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
|Arthritis Care & Research|2012|1.8k
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
|UNC Libraries|2020|1.3k